Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
7
8
9
10
11
12
13
14
15
16
17
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
281
562
843
1124
1405
1686
1967
2248
2529
2810
BAT4306F
/ Bio-Thera Solutions
BAT7104
/ Bio-Thera Solutions
BCMA-CD19 cCAR T cells
/ iCell Gene Therap
BGB-B167
/ BeiGene
BI 765049
/ Boehringer Ingelheim
BNT142
/ BioNTech
BPI-1178
/ Beta Pharma
BRL-201
/ BRL Medicine
BS006
/ Wuhan Binhui Biotech
BSI-038
/ Biosion
BinD19
/ Shenzhen BinDeBio
C7R-GD2.CART cells
/ Baylor College of Medicine
CART-138
/ Chinese PLA General Hospital
CART-19/22
/ Shanghai Unicar
CART-33
/ Chinese PLA General Hospital
CART123
/ University of Pennsylvania
CB307
/ Crescendo Biologics
CBG-006
/ Carbiogene Therap
CC-90002
/ Inhibrx Biosci, BMS
CC-90006
/ BMS
CD123 CAR-T cell therapy
/ Chongqing Precision Biotech
CD147-CART
/ Air Force Medical University
CD19 Universal Chimeric Antigen Receptor T Cell
/ Suzhou Maximum Bio-tech
CD19 and CD22 targeted prime CAR-T
/ Chongqing Precision Biotech
CD19-TriCAR-SILK therapy
/ Timmune Biotech
CD19/CD22 CAR-T cell therapy
/ Shanghai Yake Biotech
CD19/CD22 chimeric antigen receptor T cell
/ Kecellitics Biotech
CD19CAR-28-zeta T cells
/ Baylor College of Medicine
CD19CAR/virus specific T cell therapy
/ Baylor College of Medicine
CD19x22 CAR T
/ University of Colorado
CD200AR-L
/ OX2 Therap
CD33 CAR-T
/ Hedy Group, Zhejiang University
CD7 CAR-T Cell
/ iCell Gene Therap
CD8+NKG2D+ AKT cell immunotherapy
/ iCELL Biotechnology
CHO-H01
/ Cho Pharma
CLBR001/SWI019
/ AbbVie
CLIC-1901
/ Ottawa Hospital Research Institute
CLN-978
/ Cullinan Therap
CMG1A46
/ Chimagen Biosci
CMV/CD19 bi-Specific CAR T
/ City of Hope
CN1
/ Curon Biopharma
CNTY-101
/ Century Therap
CT120
/ IASO BIO
Combotox
(Imtox19/Imtox22) / Montefiore Medical Center, National Cancer Institute, Abiogen
DCSZ11
/ DynamiCure Biotech
DSP-107
/ Kahr Medical
Delito
(rituximab biosimilar) / Sino Biopharm
Duoc-01
/ Duke University Medical Center
EBV-specific anti-PD1 TCR-T cells
/ TCRCure
ESG206
/ Escugen Biotechnology
«
1
2
...
7
8
9
10
11
12
13
14
15
16
17
...
27
28
»
